Transcript drug

Chapter Thirteen:
Drugs of Abuse Other Than
Alcohol
points for consideration




Legal drugs most common
Drug use often accompanied by alcohol
Pharmacological principles
Major drug classes
use patterns 2003
alcohol
nicotine
any illicit drug
marijuana/hashish
cocaine
heroin
*
% past yr % past mo
65.0
50.1
35.1
29.8
14.7
8.2
10.6
6.2
2.5
1.0
0.1
0.1
* National Household Survey 2003
use patterns 2003
(cont.)
% past yr % past mo.
hallucinogens
LSD
PCP
ecstasy
inhalants
prescription drugs
pain medication
tranquilizers
stimulants
methamphetamine
sedatives
1.7
0.2
0.1
0.9
0.9
6.3
4.9
2.1
1.2
0.6
0.3
0.4
0.1
0.0
0.2
0.2
2.7
2.0
0.8
0.5
0.3
0.1
patterns of use
Vary by —

Type of drug


Age
Gender



Education
Employment
Geographic Area
social costs
$$$



$160.7 billion (2000)
30% of property crimes, drug-related
15% of all arrests
social costs (cont.)
$$$
Many criminal charges due solely to
illicit status
 90% marijuana arrests for possession
 80% federal budget for supply reduction
example: border patrol
Latin America “drug war”

early control efforts


First legislation
 1908 creation of Food and Drug Agency
 1914 Harrison Narcotics Act
In response to —
 indiscriminate prescribing
 over-the-counter patent medicines
current control policies

Demand side approaches
goal: decrease market for drugs
 treatment
 prevention

Supply side approaches
goal: reduce availability of drugs
 primarily criminal justice, military
pharmacological concepts






Route administration
Site of action
Solubility fat and water
Metabolism
Abuse potential
Organization by drug classes
routes of administration
Routes
 by mouth
 inhalation
 injection
 absorption through skin
Route influences —
speed of action, potential complications
solubility of drug

Substances soluble in water or fat tissue

Influences distribution in the body

Basis for drug testing
abuse potential
Abuse potential is related to —
 Speed of action
influenced by drug type
how administered
 Duration of action
 Intensity of effects
 Experience of effects
highest abuse potential
Characteristics
 intense action
 rapid onset
 short duration
Prime examples
 nicotine
 cocaine
 opiates
assessing abuse potential



Animal laboratory studies
Human laboratory studies
 comparing choice to known drug
 comparing drugs to one another
 ratings of “attractive-ness”
Surveys of use in population
use patterns as index
of abuse potential



Comparison of last year use to past month use
Limitations of index
Non-pharmacological factors important
 social acceptance
 legal status
 access
relative abuse potential
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Heroin
Crack
Nicotine
Stimulants
Pain meds
Methamphetamine
Cocaine
Sedatives
Alcohol* (adjusted)
Marijuan* (adjusted)
LSD
past year and past month
PCP
abuse potential:
% past yr. users with diagnosis of
abuse or dependent
drug
%
Nicotine
Heroin
Cocaine
Sedatives
Marijuana
Stimulants
85.0
57.4
25.6
19.0
16.6
13.7
drug
%
Pain Relievers 12.2
Alcohol
11.5
Tranquilizers
8.6
Hallucinogens 8.2
Inhalants
8.2
classification schemas



Legal status
Federal drug schedule
class influenced by abuse potential and
medical use
Pharmacological effects
schema used by American Psychiatric
Association, Diagnostic and Statistical
Manual
Controlled Substance Act
control schedule
 Schedule I




high level of abuse
no accepted medical use
examples: heroin, LSD, marijuana
Schedule II
 similar to Schedule I, but
 has accepted medical use
 prescriptions non-refillable
 examples: methadone, morphine,
amphetamines, cocaine, oxycodone
Control Schedule
(cont.)

Schedule III
 moderate risk of physical dependence
 high risk of psychological dependence
 established medical use
 examples: Vicodin, Tylenol #3

Schedule IV
 low risk of physical dependence
 moderate risk of psychological dependence
 established medical use
 examples: Ativan, Halcion, Darvon

Schedule V
 low risk of dependence
 established medical use
 example: Lomotil
DEA drug schedule
Characteristics
I
Medical use
Physical depend high
Psychological depend
High
Medium
Prescription required
non-refillable
Schedule
II
III
IV
V
x
x
x
x
x
x
x
x
x
x
x
x
x
x
classes of abused drugs






Nicotine
Opiates
Stimulants
Hallucinogens
and dissociatives
Cannabinoids
Steroids
nicotine
 Cigarettes, cigars, chewing tobacco




Frequently accompanies other drug use
High abuse potential
Tolerance develops quickly
Nicotine receptors throughout the brain
nicotine

Dangers largely due to
smoking not the nicotine

Substantial morbidity

Major cause of mortality
(cont.)
nicotine: use patterns




Current smokers 25% U.S. population
Additional 5% use other nicotine products
Virtually no difference by sex
Initiation of use
 use increases markedly between age 12 &16
 at age 21, 40% are smokers
 rate of decline much slower
only in late 50s that % equals rate at age 16
nicotine: use patterns
(cont.)
racial/ethnic groups
Racial/ethnic
groups
Percent
regular smokers
Native Americans
Whites
African Americans
Hispanics
Asians
42%
26%
23%
21%
17%
nicotine: use patterns
(cont.)
other demographic factors
Education
Less smoking with more education
Work status
Unemployed, highest rate smoking
Region
South, highest rate of smokers
West, lowest rate
Type of
community
Highest rates in rural areas, lowest
rates in metropolitan areas
nicotine: absorption
Absorption
 when smoked tar droplets inhaled
 nicotine moves from lungs to bloodstream
 reaches brain 10-19 sec.
 other routes less rapid
Dose variable, depends on smoking patterns
Wad of chew tobacco = 4 1/2 cigarettes
nicotine: pharmacology
Half-life of nicotine = 2 hours
 More than 1 cigarette per a two hour period
 build-up of nicotine during day
Metabolized by liver
Cotinine major metabolic product
 levels 15 that of nicotine
 marker of nicotine
 half-life 16 hours
 physical impact unclear
nicotine: treatment



Smoking cessation through hospitals, clinics
Success rates between 15% - 20%
Treatment = patient education
group support
counseling
nicotine replacement
opiates





historical notes
Opium known over 10,000 years ago
A mainstay of medicine
Laudanum developed 1500 (alcohol+opium)
Use continued through 1800s
Outlawed in US by Pure Food and Drug Act 1906
opiates
historical notes
Early 1800s opium poppies refined to morphine
 refinement increases potency
 morphine 10x more potent
Syringe introduced 1853
 route of administration IV use
 first extended medical use, Civil War
 addiction common, “army disease”
Early 20th century, addiction largely iatrogenic
opiates
pharmacological notes
Heroin
 synthesized from morphine, 1898
 intended for persistent cough
 20 times more potent than opium
 rapid onset and short half-life
 metabolites pharmacologically active
 use declined with passage of
Pure Food & Drug and Harrison Acts
opiates
use patterns
Popularity waxes and wanes
 related to supply
 impact of “generational” memories
Recent emergence with new set of users
 lower price
 greater purity, so smoking
 street dealers began trading heroin
Use peaked in 1996
opiates
medical issues
Compounds differ in length of action
 shorter the duration, more intense withdrawal
Detoxification
 substitute methadone then taper off
 less medical risk than alcohol withdrawal
New detox techniques
 rapid detoxification
 ultra-rapid detoxification
under anesthesia, use of blocking agent
Drug maintenance
 methadone or buprenorphine
opiates
Includes
 heroin
 fentanyl
 codeine
Route of administration
 intravenous
 smoking
 patch
Length of action: variable
 heroin: 3-4 hrs
summary







oxycodone
methadone
morphine
smoking
oral
snorting
methadone: 12 hrs -days
opiates
summary (cont.)
Desired effects
 the “rush” or high
 feelings of intense pleasure
Other acute effects
 sedation
 decreased pain

constricted pupils
Intoxication/Overdose
 decreased respiration
 decreased blood pressure
 possible stupor
 depressed respiration
opiates



Common problems
 rapid tolerance
 dependence
 HIV/AIDs
Withdrawal symptoms
 craving
 perspiration
 cramps
Interaction with alcohol
 potentiation
summary (cont.)



infection
cellulitis (injection sites)
hepatitis
sleep difficulty
 fever
 nausea

sedative-hypnotics
Central nervous system depressants
 Patterns of use
general population: under 2%
 Examples
benzodiazepines
barbiturates
meprobamate

sedative-hypnotics
(cont.)
GHB (gamma-hydroxybutyrate)









synthesized in 1960
intended as relaxant, short anesthetic
limited medical use
1980s touted as body builder
banned as dietary supplement
club drug
attraction is its disinhibiting and relaxant effect
source, not drug diversion, but illicit labs
problem: dose causing euphoria close to
dose for sedation
sedative-hypnotics
(cont.)
Route of administration
 oral
Length of action variable
Desired effects
 anxiety reduction
 similar to alcohol
Other acute effects
 sedation
 impaired driving
 repressed respiration with overdose
sedative-hypnotics
(cont.)
Intoxication and overdose
 possible decreased respiration
 slurred speech
 stupor
 coma/death (unlikely with benzodiazepines)
Withdrawal symptoms
 similar alcohol, but slower onset
 anxiety
 sweating and tremulousness
sedative-hypnotics
(cont.)
Interaction with alcohol

Potentiation
 especially breathing

Cross-tolerance

Basis for use in alcohol detoxification
stimulants
Name derives from action on CNS
Includes legal and illicit drugs
 amphetamines
 methylphenidate (Ritalin®)
 cocaine
 illicitly manufactured amphetamines
stimulants: amphetamines





Once widely prescribed
Prescriptions peaked late 1960s
Available as pills, liquids, powders
Route of administration: oral or intravenous
Methamphetamine (a derivative)
 made in home labs
stimulants: cocaine
Cocaine use patterns
 Use peaked in 1985
 Highest rate use, ages 18-34
 More common in men
 Few racial/ethnic differences
 Use highest in metropolitan areas
stimulants: cocaine
route of administration
Route of administration
 Free-basing unlimited quantity used
 Free-basing and smoking increases risks


between 1975 and 1995, rate of use 
use down but 20 times more admissions to
emergency departments
stimulants: summary
Route of administration
drug
route
Cocaine:
Amphetamine:
Methylphenidate:
snorted, smoked (free-base)
orally, intravenously
oral, crushed and injected
stimulants: summary
Length of action
drug
Cocaine
Amphetamine
Methamphetamine
length action
lasts 20-30 min
8-12 hours
8-24 hours
(con’t.)
stimulants: summary


(con’t.)
Desired effects
 Increased alertness, sense well-being,
increased energy
Other acute effects
 Anxiety, confusion
 Possible medical problems
stimulants: summary


(con’t.)
Intoxication/overdose
 heart rate up
 elevated blood pressure
 cardiac arrhythmias
Common problems
 dependence
 social withdrawal
 medical complications
 methamphetamine, long-term CNS damage
stimulants: summary



(con’t.)
Withdrawal
 depression
 lack of pleasure
 craving
Alcohol interactions
 decreases side effects
Alcohol-cocaine special problems
 cocaethylene, psychoactive by-product
 cocaethylene, similar effects as cocaine
 cocaethylene, medical risks
hallucinogens and
dissociatives

Hallucinogens
 earliest
 plants
 used religious rituals
 mescaline, psilocybin, LSD
hallucinogens and
dissociatives

Dissociatives
 different chemically
 effects similar
 medical use abandoned, due to effects
 used at raves

Include
 anesthetics
 ketamine
 phencyclidine (PCP)
 MDMA (ecstasy)
hallucinogens and
dissociatives
PCP (phencyclidine)
 anesthetic
 easily manufactured
 inexpensive
 active as liquid, powder, or crystal
 common adulterant in street drugs
hallucinogens and
dissociatives
MDMA (ecstasy )
 designer drug
 analog of methamphetamine
 classified here, hallucinogenic properties
 used at raves, “club drug”
hallucinogens and
dissociatives
Use patterns
 Largest group, 18-20 year olds
 rate of use, 7.8%
 drops significantly by age 25

More common among —
 whites
 higher household incomes
hallucinogens and
dissociatives
summary
Route of Administration
 LSD-like



MDMA-like
PCP
Ketamine
smoked
oral or smoked
smoked, oral, snorted
liquid form easily converted
to powder, then smoked
hallucinogens and
dissociatives
summary
Length of action
varies
Desired effects
blurred sense of self
hallucinations
more vivid senses
Other acute effects
variable
ketamine (k-hole)
panic attacks
hallucinogens and
dissociatives
summary
varies
common
increased blood pressure
increased heart rate
elevated temperature
Common problems flashbacks
after-images
jaw- teeth-clenching
Intoxication
hallucinogens and
dissociatives
summary
Alcohol
interaction
increased risk dehydration
Withdrawal
none (LSD and MDMA)
unclear (ketamine)
Dependence
possible ketamine
cannabinoids
Marijuana, hashish, hash oil
 Active ingredient THC

Derived from hemp plant
 Historical
 colonists imported from Europe for hemp
 psychoactive properties known
 also a medicine into 1800s

cannabinoids: use
Use for psychoactive properties last century
 “bohemians” 1920s and 1930s
 “counter-culture” of the 1960s
 Currently, use not uncommon
 higher strengths than before
 cultivated as cash crop

cannabinoids: use patterns
Most widely used illicit drug
 7% total population, over age 11
 24% ages 18-25
 Use more common among
 men
 in metropolitan areas
 racial/ethnic groups, little difference

cannabinoids:
societal perspectives
Many distinguish marijuana from other
illicit drugs
 less social disapproval
 considered private matter
 dependence risk lower
 medical consequence less than alcohol
 decriminalization being promoted
cannabinoids: medical use
Efforts to legalize medical use

Occurring through state referendum

Federal opposition

Mixed medical opinions
Dronabinol® (THC) already available

Proposed medical uses
pain relief, glaucoma, post-chemotherapy
cannabinoids: clinical issues
Clients with marijuana-related problems
 By definition
 use not discrete, not private
 nor non-problematic
 Initiate self-examination
 to identify problems
 assess relationship
cannabinoids:
summary

Desired effects
relaxation
euphoria
altered perceptions

Other acute
effects
slowed reaction time
dizziness
difficulty expressing thoughts

Intoxication/
overdose
increased respiration
increased heart beat
paranoia
not lethal depression vital centers
cannabinoids:
summary

Withdrawal/Dependence
 in some regular heavy users

Symptoms
 irritability
 agitation



depression
anxiety
Long-term physical effects
 respiratory smoking-related
(cont.)
Inhalants
Fumes of products inhaled for psychoactive effects
Three different chemical classes
 Hydro-carbons:
common household products
 Nitrates:
name from chemical formula
 Nitrates
form of anesthesia, laughing gas
inhalants: use patterns

Age
most popular adolescents
 easily available
 inexpensive
 commonly group activity
 no college expectations

Geography
highest in west

Racial/ethnic highest among Hispanics
inhalants:
effects

Examples
 paints, aerosols, gasoline,
glue, vasodilators

Route
 “huffing” (inhalation)

Desired effects
 rush, euphoria,
disinhibition
enhance intercourse

Other acute
effects
 cardiac depression
 increased blood pressure
 “sudden sniffing death”
inhalants:
effects

Withdrawal

craving
 little research

Alcohol
interactions

potentiation with
hydro-carbons
club drugs
Not a single drug class
 Associated with raves
all-night dancing, electronic music,
laser light shows and drug use
 Major club drugs
ecstasy
PCP
rohypnol (benzodiazepine)
GHB (classed with sedatives)
 Often taken with along with alcohol
steroids
 Not used for psychoactive properties




male hormones
used to enhance athletic performance
used to enhance physical appearance
Use patterns
 starting at younger age
 little data
 high school seniors, 2.9%
steroids: summary
(cont.)
 Route of administration




tablet
injected into muscle
Pattern of administration
 cycle intended to enhance performance
 on-off cycles, different steroid
Intoxication/Overdose
 rare
steroids: summary
(cont.)
 Common problems






Physical changes — virilizing effects
Differ by gender
Men: male-pattern baldness, acne
Women: menstrual irregularities
Longer term: liver disorder, liver cancer
Psychiatric problems
 aggressive behavior
 hypomania
 depression
treatment issues
 Treatment goals



Role of harm reduction
Pharmacological therapy
Prenatal drug exposure
pharmacological therapy



Drug Replacement
 prescription of same
or similar drugs
nicotine patch
methadone
Anti-craving agents
 reduce craving
Zyban® smoking cessation
Blocking agents
 prevent effects of a
drug
naltrexone
an opiate agonist
prenatal drug exposure
Drug use in pregnancy major concern

passes to fetus

disrupts fetal development

difficulties in pregnancy
Illicit drug use during pregnancy
 African Americans 11.3 %

Hispanics, 4.5 %

whites, 4.4%

in absolute numbers, majority are white
prenatal drug exposure
Rates of drug use during pregnancy






Nicotine
Alcohol
Any illicit use
Marijuana
Cocaine
Other illicit
20.0 %
18.8 %
5.5 %
2.9 %
1.1 %
1.1 %
(cont.)
prenatal drug exposure:
cocaine
Easily transferred to fetus
 soluble, both water and fat
 smoking or injecting  transfer
Effects




constriction of blood vessels
premature labor
increased still births
“crack babies” (delayed development)
little research support
prenatal drug exposure:
opiates
Problems from drug effect and circumstances
 Poor injection practice
 High-risk environment
 No prenatal care
Major complications
 Low birth weight
 Premature birth
 Respiratory problems
 Neonatal withdrawal
neonatal opiate withdrawal
Occurs in 60-90% infants
Symptoms
 Irritability
 Tremors
 Startle easily
 GI problems
 High-pitched cry
 Respiratory distress
 Nursing difficult, frequent regurgitation
neonatal opiate withdrawal
(cont.)
Factors influencing
 Level of maternal use
 Use close to delivery, delays withdrawal
 Maturity of baby’s own system,
related to ability to metabolize
 Duration can last several days to weeks
 Drug therapy may be used for detox
neonatal methadone
exposure
 No complications for neonate


Proper maternal dose important
Methadone use provides benefits of
contact with health care setting
drug use - pregnancy
social and legal issues
Approaches to drug-dependent women: both
therapeutic and punitive
 special treatment programs
 coercive treatment
 importance of post-pregnancy support
 arrests for child endangerment